Keyphrases
Molecular Docking
100%
Antibacterial Activity
58%
Antibacterial Agents
53%
Ferulic Acid
50%
Hibiscus Sabdariffa
47%
Flavonoids
47%
Cyclooxygenase-2
43%
Methicillin-resistant Staphylococcus Aureus
39%
Cyclooxygenase-1 (COX-1)
31%
Escherichia Coli
31%
P-coumaric Acid
29%
DNA Gyrase
26%
2 Receptor
25%
Antiplatelet Activity
23%
Chick Embryo Chorioallantoic Membrane
23%
Ferulic Acid Derivatives
23%
Luteolin Derivatives
23%
PBP2a
23%
Clinical Chemistry
23%
Cheminformatics
23%
Gossypol
23%
Drug Design
23%
Pharmaceutical Chemistry
23%
Derivative-based
23%
Boesenbergia Pandurata
23%
Antitumor Activity
23%
Roxb
23%
Vanillin
23%
ADMET Prediction
23%
Angiogenesis
23%
Chick Chorioallantoic Membrane Assay
23%
Multidrug Resistance
23%
Microencapsulation
23%
5-O-benzoylpinostrobin
23%
Activity Evaluation
23%
β-lactamase
23%
Microcapsules
23%
Vascular Endothelial Growth Factor
23%
Alginate Dialdehyde
23%
Lactobacillus Plantarum
23%
Physical Properties
23%
In Silico Analysis
23%
Roselle
23%
MCF-7 Cancer Cell Line
23%
P2Y12 Receptor
23%
In Vitro Anticancer Study
23%
Docking Time
23%
Time Evaluation
23%
Benzoxazinone Derivatives
23%
Binding Affinity
22%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
59%
Antibacterial Activity
57%
Ferulic Acid
50%
Cyclooxygenase 2
47%
Hibiscus sabdariffa
47%
Flavonoid
47%
Escherichia coli
35%
Methicillin-Resistant Staphylococcus Aureus
35%
Receptor
30%
Drug Development
27%
Absorption-Distribution-Metabolism-Excretion Toxicity
27%
DNA Topoisomerase (ATP Hydrolysing)
26%
Anticoagulant Agent
26%
Extended Spectrum Beta Lactamase
25%
Antitumor Activity
23%
Gelatin
23%
Anti-Inflammatory Drug
23%
Lactobacillus plantarum
23%
Pharmaceutical Chemistry
23%
Luteolin
23%
Breast Cancer
23%
Penicillinase
23%
Gossypetin
23%
Vanillin
23%
Chick
23%
Vasculotropin
23%
Cyclooxygenase 1
23%
Cyclooxygenase 1 Inhibitor
23%
Multidrug Resistance
23%
Purinergic P2Y12 Receptor
23%
Benzoxazinone Derivative
23%
Mefenamic Acid
17%
Microparticle
17%
Hydroxycarbamide
17%
Breast Carcinoma
17%
Binding Site
17%
Alginic Acid
17%
IC50
11%
Non-Steroidal Anti-Inflammatory Drug
11%
Microsphere
11%
Side Effect
9%
Vanillin Derivative
9%
Prostacyclin
9%
Ischemic Heart Disease
9%
Benzoic Acid
9%
Lead Compound
9%
Vasculotropin C
8%
Celecoxib
8%
Blood-Brain Barrier
7%
Ciprofloxacin
6%